We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12.2B
AUM Growth
+$1.03B
Cap. Flow
+$49.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
25.44%
Holding
2,628
New
63
Increased
565
Reduced
814
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 12.24%
3 Financials 12%
4 Consumer Discretionary 11.44%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPL icon
1876
Replimune Group
REPL
$1.42B
$267K ﹤0.01%
9,865
FBMS
1877
DELISTED
The First Bancshares, Inc.
FBMS
$267K ﹤0.01%
6,912
MTUS icon
1878
Metallus
MTUS
$892M
$267K ﹤0.01%
16,152
TDAY
1879
USA Today Co
TDAY
$1B
$264K ﹤0.01%
49,593
+10,537
+27% +$58.8K
TRNS icon
1880
Transcat
TRNS
$888M
$264K ﹤0.01%
2,858
FRTA
1881
DELISTED
Forterra, Inc
FRTA
$264K ﹤0.01%
11,105
RAD
1882
DELISTED
Rite Aid Corporation
RAD
$263K ﹤0.01%
17,917
VTOL icon
1883
Bristow Group
VTOL
$1.38B
$263K ﹤0.01%
8,308
PNTG icon
1884
Pennant Group
PNTG
$1.35B
$262K ﹤0.01%
11,360
COLL icon
1885
Collegium Pharmaceutical
COLL
$913M
$262K ﹤0.01%
14,032
DOUG icon
1886
Douglas Elliman
DOUG
$183M
$261K ﹤0.01%
+23,841
New +$268K
LTH icon
1887
Life Time Group Holdings
LTH
$9.9B
$261K ﹤0.01%
+15,138
New +$283K
RXT icon
1888
Rackspace Technology
RXT
$1.1B
$260K ﹤0.01%
19,337
KOP icon
1889
Koppers
KOP
$874M
$260K ﹤0.01%
8,316
CSII
1890
DELISTED
Cardiovascular Systems, Inc.
CSII
$260K ﹤0.01%
13,837
RETA
1891
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$259K ﹤0.01%
9,837
AORT icon
1892
Artivion
AORT
$1.39B
$259K ﹤0.01%
12,730
TRST
1893
Trustco Bank Corp NY
TRST
$971M
$258K ﹤0.01%
7,756
FMBH icon
1894
First Mid Bancshares
FMBH
$1.39B
$258K ﹤0.01%
6,036
ACEL icon
1895
Accel Entertainment
ACEL
$1.01B
$258K ﹤0.01%
19,825
+6,044
+44% +$76.8K
PRAX icon
1896
Praxis Precision Medicines
PRAX
$10.3B
$258K ﹤0.01%
873
+150
+21% +$44K
CFB
1897
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$258K ﹤0.01%
16,519
SLP icon
1898
Simulations Plus
SLP
$370M
$258K ﹤0.01%
5,451
NRC icon
1899
NRC Health Common Stock
NRC
$471M
$258K ﹤0.01%
6,206
IDYA icon
1900
IDEAYA Biosciences
IDYA
$3.53B
$258K ﹤0.01%
10,897

Similar funds

MetLife Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, MetLife Investment Management held 2,628 positions worth $12.2B, up 9.2% from $11.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2021 filing shows 63 new, 565 increased, 814 reduced and 130 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M. The largest sale was Enterprise Products Partners, an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M.
  • MetLife Investment Management added most to iShares Russell 2000 ETF in Q4 2021, an estimated $14.1M increase.
  • MetLife Investment Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $31.2M.
  • MetLife Investment Management fully exited Enterprise Products Partners in Q4 2021, selling an estimated $31.9M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.2B portfolio in Q4 2021.
  • MetLife Investment Management opened 63 new positions and closed 130 in Q4 2021.
  • MetLife Investment Management's portfolio value rose 9.2% quarter-over-quarter to $12.2B.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.